3 unchanged sentences
Prior to that date, there was no public trading market for our common stock.
−Removed: As of March 15, 2021, we had 53 holders of record of our common stock.
+Added: As of February 25, 2022, we had 53 holders of record of our common stock.
Because many of our shares of common stock are held by brokers and other institutions on behalf of shareholders, we are unable to estimate the total number of beneficial owners of our common stock represented by these holders.
+Added: Performance Graph
+Added: The following graph shows a comparison of the total cumulative shareholder returns of an investment of $100 in cash from August 19, 2020, the day we began trading, through December 31, 2021 in (i) our common stock, (ii) the Nasdaq Biotechnology Index, and (iii) the Nasdaq Composite Index.
+Added: The shareholder returns in the graph below is not necessarily indicative of future performance.
Dividend Policy
2 unchanged sentences
Any such determination will also depend upon our business prospects, results of operations, financial condition, cash requirements and availability, industry trends and other factors that our board of directors may deem relevant.
−Removed: On August 21, 2020, we completed the IPO of our common stock, in which we issued and sold 6,151,162 shares, including 802,325 shares pursuant to the underwriters’ over-allotment option at a price of $24.00 per share for an aggregate price of approximately $147.6 million.
−Removed: The shares began trading on the Nasdaq Global Market on August 19, 2020.
+Added: Initial Public Offering
+Added: In August 2020, we completed the IPO of our common stock, in which we issued and sold 6,151,162 shares, including 802,325 shares pursuant to the underwriters’ over-allotment option at a price of $24.00 per share for an aggregate
+Added: price of approximately $147.6 million.
The offer and sale of the shares in our IPO was registered under the Securities Act pursuant to a registration statement on Form S-1 (File No.
333-240122), which was declared effective by the SEC on August 18, 2020 (the “Registration Statement”).
−Removed: The offering commenced on August 6, 2020 and terminated after the sale of all securities registered pursuant to the Registration Statement.
−Removed: Goldman Sachs & Co.
−Removed: LLC, Jefferies LLC and Piper Sandler & Co.
−Removed: acted as managing underwriters for the offering.
We raised approximately $135.4 million, after deducting underwriting discounts and commissions and offering expenses of approximately $12.2 million.
3 unchanged sentences
Recent Sales of Unregistered Securities
−Removed: Between January 1, 2020 and August 17, 2020, we issued to certain employees and directors an aggregate of 21,836 shares of our common stock upon the exercise of options issued under the 2017 Equity Plan at an exercise price of $8.22 per share, for an aggregate exercise price of $0.2 million.
Unless otherwise stated, the sales of the above securities were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act (or Regulation D or Regulation S promulgated thereunder), or Rule 701 promulgated under Section 3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701.
The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions.
−Removed: Selected Financial Data.
−Removed: Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.